We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.13 | 0.34% | 38.76 | 1,701 | 09:10:36 |
From Oct 2019 to Oct 2024
By Ian Walker
GlaxoSmithKline PLC on Friday advised holders of American Depositary Shares to reject a mini tender offer by TRC Capital Investment Corporation as the price offered falls short of their trading price.
Glaxo said it has been notified that TRC Capital has offered to buy up to 3 million ADS' for $37.10 each, in cash. It added that the price offered is a 4.5% discount to the closing price of $38.85 per ADS on May 21, the last trading day before the offer started. ADS' closed at $38.71 on Thursday.
"This mini-tender offer is at a price below the closing price for GSK's ADSs (as of the last trading day prior to the offer) and is subject to numerous conditions," Glaxo said Friday.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
June 04, 2021 11:35 ET (15:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
